losartan has been researched along with Idiopathic Parkinson Disease in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grammatopoulos, TN | 1 |
| Outeiro, TF | 1 |
| Hyman, BT | 1 |
| Standaert, DG | 1 |
| Sarma, GRK | 1 |
| Kamath, V | 1 |
| Mathew, T | 1 |
| Roy, AK | 1 |
2 other studies available for losartan and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro.
Topics: alpha-Synuclein; Angiotensin II; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Humans; Imid | 2007 |
A case of parkinsonism worsened by losartan: a probable new adverse effect.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Dopamine Agonists; Drug Interactions; Humans; Hyperte | 2008 |